Valproic acid sodium

Cat. No.: IBDI-436767

Valproic acid (Sodium Valproate) sodium is an orally active HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid sodium activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid sodium is used in the treatment of epilepsy, bipolar disorder, metabolic disease, HIV infection and prevention of migraine headaches.

Product Details

Target	HDAC | Autophagy | Mitophagy | HIV | Notch | Apoptosis | Endogenous Metabolite
Molecular Weight	166.19
Appearance	Solid
Synonyms	Sodium Valproate sodium
SMILES	O=C(O[Na])C(CCC)CCC
Purity	98.14%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.